|
Fortress Acquisition Sponsor Ii Llc
|
Non-Executive |
ATI Physical Therapy, Inc. (ATI)
|
2021-06-16 |
$10.00 |
499.4% |
$374,549,993
|
7,500,000
|
$75,000,000 |
|
Bain Capital Investors Llc
|
Non-Executive |
Cerevel Therapeutics Holdings, Inc. (CERE)
|
2020-10-27 |
$10.00 |
349.6% |
$349,599,990
|
10,000,000
|
$100,000,000 |
|
Gordon Christopher R
|
Non-Executive Director |
Cerevel Therapeutics Holdings, Inc. (CERE)
|
2020-10-27 |
$10.00 |
349.6% |
$349,599,990
|
10,000,000
|
$100,000,000 |
|
Koppel Adam
|
Non-Executive Director |
Cerevel Therapeutics Holdings, Inc. (CERE)
|
2020-10-27 |
$10.00 |
349.6% |
$349,599,990
|
10,000,000
|
$100,000,000 |
|
Washington State Investment Board
|
Non-Executive |
Fortress Transportation & Infrastructure Investors LLC (FTAI)
|
2020-04-03 |
$8.50 |
1298.9% |
$259,773,218
|
2,353,400
|
$19,998,967 |
|
Garcia Ernest C. Ii
|
Non-Executive |
CARVANA CO. (CVNA)
|
2022-06-13 |
$21.18 |
566.4% |
$238,152,502
|
1,985,258
|
$42,046,810 |
|
Wood River Capital, Llc
|
Non-Executive |
ASPEN AEROGELS INC (ASPN)
|
2022-11-30 |
$9.50 |
169.5% |
$169,473,688
|
10,526,316
|
$100,000,002 |
|
Iac/Interactivecorp
|
Non-Executive |
MGM Resorts International (MGM)
|
2020-08-07 |
$18.50 |
93.6% |
$168,026,230
|
9,705,785
|
$179,537,941 |
|
Perceptive Advisors Llc
|
Non-Executive |
Prometheus Biosciences, Inc. (RXDX)
|
2021-03-16 |
$19.00 |
952.2% |
$153,781,998
|
850,000
|
$16,150,000 |
|
Dell Michael S
|
Chief Executive Officer |
Dell Technologies Inc. (DELL)
|
2020-03-20 |
$16.07 |
566.7% |
$148,780,630
|
1,633,392
|
$26,253,713 |
|
Rtw Investments, Lp
|
Non-Executive |
Prometheus Biosciences, Inc. (RXDX)
|
2021-03-16 |
$19.00 |
952.2% |
$144,735,998
|
800,000
|
$15,200,000 |
|
Duggan Robert W
|
Chief Executive Officer |
Summit Therapeutics Inc. (SMMT)
|
2020-11-06 |
$3.34 |
274.3% |
$128,898,201
|
14,071,856
|
$46,999,999 |
|
Garcia Ernest C. Iii
|
Chief Executive Officer |
CARVANA CO. (CVNA)
|
2022-04-26 |
$80.00 |
76.4% |
$122,279,998
|
2,000,000
|
$160,000,000 |
|
Gordon Christopher R
|
Non-Executive Director |
Cerevel Therapeutics Holdings, Inc. (CERE)
|
2023-10-16 |
$22.81 |
97.1% |
$121,383,146
|
5,480,052
|
$124,999,986 |
|
Bain Capital Investors Llc
|
Non-Executive |
Cerevel Therapeutics Holdings, Inc. (CERE)
|
2023-10-16 |
$22.81 |
97.1% |
$121,383,146
|
5,480,052
|
$124,999,986 |
|
Koppel Adam
|
Non-Executive Director |
Cerevel Therapeutics Holdings, Inc. (CERE)
|
2023-10-16 |
$22.81 |
97.1% |
$121,383,146
|
5,480,052
|
$124,999,986 |
|
Quiroga Moreno Isidoro
|
Non-Executive |
Enphase Energy, Inc. (ENPH)
|
2019-11-20 |
$19.15 |
485.4% |
$114,426,905
|
1,231,275
|
$23,574,399 |
|
Green Equity Investors Vii, L.P.
|
Non-Executive |
WESCO INTERNATIONAL INC (WCC)
|
2020-07-14 |
$35.78 |
324.9% |
$111,918,582
|
962,805
|
$34,447,038 |
|
Duggan Robert W
|
Non-Executive Director |
Pulse Biosciences, Inc. (PLSE)
|
2023-05-09 |
$6.51 |
168.5% |
$109,951,619
|
10,022,937
|
$65,249,320 |
|
Chen Bihua
|
Non-Executive |
MoonLake Immunotherapeutics (MLTX)
|
2022-04-05 |
$10.00 |
355.8% |
$101,403,006
|
2,850,000
|
$28,500,000 |
|
Sr One Capital Management, Llc
|
Non-Executive |
Arcellx, Inc. (ACLX)
|
2022-02-08 |
$15.00 |
369.1% |
$92,283,357
|
1,666,667
|
$25,000,005 |
|
Cohen Ryan
|
Non-Executive |
GameStop Corp. (GME)
|
2020-12-18 |
$3.88 |
477.3% |
$90,810,501
|
4,905,600
|
$19,025,878 |
|
Dunlap Michael S
|
Executive Chairman of Board |
NELNET INC (NNI)
|
2020-05-12 |
$44.57 |
150.6% |
$90,424,067
|
1,347,200
|
$60,044,704 |
|
Tpg Group Holdings (Sbs) Advisors, Inc.
|
Non-Executive |
Vaxcyte, Inc. (PCVX)
|
2020-06-16 |
$16.00 |
600.6% |
$90,093,748
|
937,500
|
$15,000,000 |
|
New Enterprise Associates 15, L.P.
|
Non-Executive |
Arcellx, Inc. (ACLX)
|
2022-02-08 |
$15.00 |
369.1% |
$87,669,153
|
1,583,333
|
$23,749,995 |
|
Cormorant Asset Management, Lp
|
Non-Executive |
Ambrx Biopharma Inc. (AMAM)
|
2023-04-20 |
$11.30 |
147.7% |
$87,074,602
|
5,215,189
|
$58,950,690 |
|
Cui Xiangmin
|
Non-Executive Director |
ALPINE IMMUNE SCIENCES, INC. (ALPN)
|
2021-09-17 |
$9.40 |
591.2% |
$85,719,672
|
1,542,553
|
$14,499,998 |
|
Decheng Capital China Life Sciences Usd Fund Iii, L.P.
|
Non-Executive |
ALPINE IMMUNE SCIENCES, INC. (ALPN)
|
2021-09-17 |
$9.40 |
591.2% |
$85,719,672
|
1,542,553
|
$14,499,998 |
|
Duggan Robert W
|
Chief Executive Officer |
Summit Therapeutics Inc. (SMMT)
|
2021-05-12 |
$5.24 |
138.5% |
$82,516,586
|
11,365,921
|
$59,557,426 |
|
Moroun Matthew T
|
Non-Executive Director |
UNIVERSAL LOGISTICS HOLDINGS, INC. (ULH)
|
2021-12-20 |
$14.94 |
176.2% |
$81,382,844
|
3,090,879
|
$46,177,732 |
|
Ra Capital Management, L.P.
|
Non-Executive Director |
Janux Therapeutics, Inc. (JANX)
|
2021-06-15 |
$17.00 |
157.1% |
$78,558,808
|
2,941,176
|
$49,999,992 |
|
Jab Holdings B.V.
|
Non-Executive |
Keurig Dr Pepper Inc. (KDP)
|
2020-03-09 |
$27.00 |
36.9% |
$73,778,007
|
7,400,000
|
$199,800,000 |
|
Jab Holdings B.V.
|
Non-Executive |
Keurig Dr Pepper Inc. (KDP)
|
2020-05-22 |
$27.10 |
36.4% |
$72,840,607
|
7,380,000
|
$199,998,000 |
|
Mfn Partners, Lp
|
Non-Executive |
RXO, Inc. (RXO)
|
2024-08-12 |
$20.21 |
34.9% |
$72,381,011
|
10,266,810
|
$207,492,230 |
|
Sarofim Christopher Binyon
|
Non-Executive Director |
Sable Offshore Corp. (SOC)
|
2024-02-14 |
$10.00 |
116.1% |
$69,660,006
|
6,000,000
|
$60,000,000 |
|
Flynn James E
|
Non-Executive Director |
Larimar Therapeutics, Inc. (LRMR)
|
2022-09-16 |
$3.15 |
182.5% |
$63,888,871
|
11,111,108
|
$34,999,990 |
|
Andreessen Horowitz Lsv Fund Iii, L.P.
|
Non-Executive |
Samsara Inc. (IOT)
|
2021-12-17 |
$23.00 |
68.5% |
$62,931,519
|
3,995,652
|
$91,899,996 |
|
Andreessen Marc L
|
Non-Executive Director |
Samsara Inc. (IOT)
|
2021-12-17 |
$23.00 |
68.5% |
$62,931,519
|
3,995,652
|
$91,899,996 |
|
Ah Parallel Fund Iv, L.P.
|
Non-Executive |
Samsara Inc. (IOT)
|
2021-12-17 |
$23.00 |
68.5% |
$62,931,519
|
3,995,652
|
$91,899,996 |
|
Andreessen Horowitz Fund Iv, L.P.
|
Non-Executive |
Samsara Inc. (IOT)
|
2021-12-17 |
$23.00 |
68.5% |
$62,931,519
|
3,995,652
|
$91,899,996 |
|
Viking Global Investors Lp
|
Non-Executive |
RayzeBio, Inc. (RYZB)
|
2023-09-19 |
$18.00 |
247.2% |
$61,791,674
|
1,388,889
|
$25,000,002 |
|
Viking Global Investors Lp
|
Non-Executive |
RayzeBio, Inc. (RYZB)
|
2023-09-19 |
$18.00 |
247.2% |
$61,791,674
|
1,388,889
|
$25,000,002 |
|
Tiger Global Management Llc
|
Non-Executive |
Apollo Global Management, Inc. (APO)
|
2021-03-11 |
$47.22 |
130.5% |
$61,626,570
|
1,000,000
|
$47,223,428 |
|
Perceptive Advisors Llc
|
Non-Executive |
ADMA BIOLOGICS, INC. (ADMA)
|
2020-02-11 |
$3.50 |
378.3% |
$60,423,388
|
4,563,700
|
$15,972,950 |
|
Ecor1 Capital, Llc
|
Non-Executive |
ANAPTYSBIO, INC (ANAB)
|
2021-03-09 |
$18.93 |
94.4% |
$59,108,019
|
3,308,800
|
$62,622,736 |
|
Arc Global Investments Ii Llc
|
Non-Executive |
Digital World Acquisition Corp. (DWACU)
|
2021-09-08 |
$10.00 |
513.5% |
$58,204,401
|
1,133,484
|
$11,334,840 |
|
Orlando Patrick Francis
|
President and CEO |
Digital World Acquisition Corp. (DWACU)
|
2021-09-08 |
$10.00 |
513.5% |
$58,204,401
|
1,133,484
|
$11,334,840 |
|
Cascade Investment, L.L.C.
|
Non-Executive |
REPUBLIC SERVICES, INC. (RSG)
|
2022-02-24 |
$116.83 |
75.8% |
$56,459,970
|
637,253
|
$74,450,909 |
|
Thompson Peter A.
|
Non-Executive Director |
ALPINE IMMUNE SCIENCES, INC. (ALPN)
|
2021-09-17 |
$9.40 |
591.2% |
$56,161,099
|
1,010,637
|
$9,499,988 |
|
Orbimed Advisors Llc
|
Non-Executive Director |
ALPINE IMMUNE SCIENCES, INC. (ALPN)
|
2021-09-17 |
$9.40 |
591.2% |
$56,161,099
|
1,010,637
|
$9,499,988 |